Richard Groves

Guy's and St Thomas' NHS Foundation Trust — United Kingdom

Medicine · Health Sciences

45h-index7.9kcitations172works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Autoimmune Bullous Skin Diseases(59), Urticaria and Related Conditions(33), Coagulation, Bradykinin, Polyphosphates, and Angioedema(30), Immunotherapy and Immune Responses(18), Cell Adhesion Molecules Research(18)

Publications172 total

Treatment with mycophenolate mofetil as an adjuvant therapy post-rituximab does not improve treatment outcomes in pemphigus
Clinical and Experimental Dermatology·2026
P040 Clinical features, treatment and treatment response of 24 patients with epidermolysis bullosa acquisita
British Journal of Dermatology·2025Open Access
Efficacy of rituximab in the treatment of epidermolysis bullosa acquisita
Clinical and Experimental Dermatology·2024· 1 cited
Combined rituximab and belimumab to treat recalcitrant epidermolysis bullosa aquisita associated with systemic lupus erythematosus
British Journal of Dermatology·2024
Immunobullous Diseases
2024· 6 cited
Corrigendum: S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)
Journal of the European Academy of Dermatology and Venereology·2023· 4 citedOpen Access
P18 Epidermolysis bullosa acquisita in children: report of three cases
British Journal of Dermatology·2023
S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)
Journal of the European Academy of Dermatology and Venereology·2023· 52 citedOpen Access
Rituximab
2022
Updated<scp>S2</scp>K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)
Journal of the European Academy of Dermatology and Venereology·2022· 226 citedOpen Access
Epidermolysis bullosa aquisita following immune-checkpoint inhibitor treatment for metastatic melanoma
Clinical and Experimental Dermatology·2022· 3 cited
Epidermolysis bullosa acquisita: a case series of three paediatric patients
Clinical and Experimental Dermatology·2022· 2 cited
Human marginal zone B cell development from early T2 progenitors
The Journal of Experimental Medicine·2020· 74 citedOpen Access
Human marginal zone B cell development from early T2 progenitors
2020· 9 citedOpen Access
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
Journal of the European Academy of Dermatology and Venereology·2020· 319 citedOpen Access
Autoantibody Detection for Diagnosis in Direct Immunofluorescence-Negative Mucous Membrane Pemphigoid
Ophthalmology·2020· 25 citedOpen Access
BP:血清抗 BP180 IgG 水平、死亡率和卡式评分
British Journal of Dermatology·2018Open Access
Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score
British Journal of Dermatology·2018· 38 cited
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
Journal of the American Academy of Dermatology·2018· 357 citedOpen Access
British Association of Dermatologists’ guidelines for the management of pemphigus vulgaris 2017
British Journal of Dermatology·2017· 242 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

D.M. MACDONALD(7), Thomas S. Kupper(7), Enno Schmidt(6), Juliet N. Barker(6), Elizabeth Ross(5), John Mee(5), P. Joly(4), Branka Marinović(4), Takashi Hashimoto(4), Maryam Daneshpazhooh(4), Luca Borradori(4), F. Caux(4), Kossara Drenovska(4), Snejina Vassileva(4), Soner Uzun(4), Savaş Yaylı(4), Detlef Zillikens(4), Claudio Feliciani(4), José M. Mascaró(4), Cezary Kowaléwski(4)